Pfizer Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	62,579	63,627	59,554	101,175	81,288
Revenue Growth (YoY)	-1.65%	6.84%	-41.14%	24.46%	95.17%
Cost of Revenue	15,140	17,191	23,989	34,097	30,686
Gross Profit	47,439	46,436	35,565	67,078	50,602
Selling, General & Admin	12,964	14,771	13,836	12,200	9,562
Research & Development	10,437	10,822	10,679	11,428	10,360
Amortization of Goodwill & Intangibles	4,874	5,286	4,733	3,609	3,700
Operating Expenses	28,275	30,879	29,248	27,237	23,622
Operating Income	19,164	15,557	6,317	39,841	26,980
Interest Expense	-2,671	-3,091	-2,209	-1,238	-1,291
Interest & Investment Income	868	817	1,889	565	202
Earnings From Equity Investments	-	102	505	436	471
Other Non Operating Income (Expenses)	1,552	-173	-577	621	1,904
EBT Excluding Unusual Items	18,913	13,212	5,925	40,225	28,266
Merger & Restructuring Charges	-2,626	-4,039	-3,999	-2,225	-1,452
Gain (Loss) on Sale of Investments	-134	2,841	3,178	-1,273	1,344
Gain (Loss) on Sale of Assets	-	-420	-	-	-
Asset Writedown	-4,940	-3,295	-3,024	-421	-86
Legal Settlements	-1,057	-567	-474	-230	-182
Other Unusual Items	-1,022	399	-354	-394	-111
Pretax Income	7,521	8,023	1,058	34,729	24,310
Income Tax Expense	-266	-28	-1,115	3,328	1,852
Earnings From Continuing Operations	7,787	8,051	2,173	31,401	22,458
Earnings From Discontinued Operations	25	11	-15	6	-434
Net Income to Company	7,812	8,062	2,158	31,407	22,024
Minority Interest in Earnings	-41	-31	-39	-35	-45
Net Income	7,771	8,031	2,119	31,372	21,979
Net Income to Common	7,771	8,031	2,119	31,372	21,979
Net Income Growth	-3.24%	279.00%	-93.25%	42.74%	139.97%
Shares Outstanding (Basic)	5,683	5,664	5,643	5,608	5,601
Shares Outstanding (Diluted)	5,713	5,700	5,709	5,733	5,708
Shares Change (YoY)	0.23%	-0.16%	-0.42%	0.44%	1.35%
EPS (Basic)	1.37	1.42	0.38	5.59	3.92
EPS (Diluted)	1.36	1.41	0.37	5.47	3.85
EPS Growth	-3.37%	284.33%	-93.28%	41.96%	136.58%
Free Cash Flow	9,075	9,835	4,793	26,031	29,869
Free Cash Flow Per Share	1.59	1.73	0.84	4.54	5.23
Dividend Per Share	1.720	1.680	1.640	1.600	1.560
Dividend Growth	2.38%	2.44%	2.50%	2.56%	2.63%
Gross Margin	75.81%	72.98%	59.72%	66.30%	62.25%
Operating Margin	30.62%	24.45%	10.61%	39.38%	33.19%
Profit Margin	12.42%	12.62%	3.56%	31.01%	27.04%
Free Cash Flow Margin	14.50%	15.46%	8.05%	25.73%	36.74%
EBITDA	25,718	22,551	12,575	44,869	32,084
EBITDA Margin	41.10%	35.44%	21.12%	44.35%	39.47%
D&A For EBITDA	6,554	6,994	6,258	5,028	5,104
EBIT	19,164	15,557	6,317	39,841	26,980
EBIT Margin	30.62%	24.45%	10.61%	39.38%	33.19%
Effective Tax Rate	-	-	-	9.58%	7.62%
Revenue as Reported	62,579	63,627	59,553	101,175	81,288
Advertising Expenses	2,700	3,300	3,700	2,800	2,000

Source: S&P Global Market Intelligence. Standard template. Financial Sources.